Genetic testing company Myriad Genetics (NASDAQ:MYGN) fell short of the market’s revenue expectations in Q4 CY2024, but sales rose 7.1% year on year to $210.6 million. The company’s full-year revenue guidance of $850 million at the midpoint came in 1.5% below analysts’ estimates. Its non-GAAP profit of $0.03 per share was in line with analysts’ consensus estimates.
3D measurement and imaging company FARO (NASDAQ:FARO) reported Q4 CY2024 results exceeding the market’s revenue expectations, but sales fell by 5.4% year on year to $93.54 million. The company expects next quarter’s revenue to be around $81 million, close to analysts’ estimates. Its non-GAAP profit of $0.50 per share was 25% above analysts’ consensus estimates.
Video conferencing platform Zoom (NASDAQ:ZM) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 3.3% year on year to $1.18 billion. On the other hand, next quarter’s revenue guidance of $1.16 billion was less impressive, coming in 0.8% below analysts’ estimates. Its non-GAAP profit of $1.41 per share was 4.6% above analysts’ consensus estimates.
Telehealth company Hims & Hers Health (NYSE:HIMS) announced better-than-expected revenue in Q4 CY2024, with sales up 95.1% year on year to $481.1 million. On top of that, next quarter’s revenue guidance ($530 million at the midpoint) was surprisingly good and 4.6% above what analysts were expecting. Its GAAP profit of $0.11 per share was in line with analysts’ consensus estimates.
Home healthcare provider Addus HomeCare (NASDAQ:ADUS) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 7.5% year on year to $297.1 million. Its non-GAAP profit of $1.38 per share was 1.6% above analysts’ consensus estimates.
Palantir stock extended its slide over ongoing concerns of potential Pentagon budget cuts impacting the software company's revenue.
Online insurance comparison site EverQuote (NASDAQ:EVER) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 165% year on year to $147.5 million. On top of that, next quarter’s revenue guidance ($157.5 million at the midpoint) was surprisingly good and 14.3% above what analysts were expecting. Its GAAP profit of $0.33 per share was 67.9% above analysts’ consensus estimates.
Shares of database as a service company Couchbase (NASDAQ: BASE) fell 6.9% in the afternoon session after markets continued to struggle following the broad selloff triggered by weak economic data in the previous week. On Friday, February 21, 2025, the S&P 500 dropped 1.7%, and the Nasdaq fell 2.2% after PMI numbers showed the U.S. services sector contracted, and the University of Michigan's consumer sentiment index came in below expectations.
(Bloomberg) -- More than a dozen companies are selling just over $20 billion of investment-grade bonds Monday, after yields have fallen over the last week and demand for corporate debt has remained strong.Most Read from BloombergTrump Targets $128 Billion California High-Speed Rail ProjectTrump Asserts Power Over NYC, Proclaims ‘Long Live the King’NYC’s Congestion Pricing Pulls In $48.6 Million in First MonthNYC to Shut Migrant Center in Former Hotel as Crisis EasesAs Visitors Discover Ghent, th
Investors are still optimistic that Trump's moves later this year will offset the negative impacts of tariffs and Elon Musk's chainsaw.